Latest Australian Government News

Kula Gold reports promising shallow gold intersections at Mt Palmer and secures government co-funding, while launching a $1.6 million entitlement offer to fuel further exploration.

Asra Minerals has successfully completed Phase 1 drilling at its Leonora North and South gold projects, confirming significant gold mineralisation and setting the stage for an expanded Phase 2 program in March 2025.

Alchemy Resources Limited has received FIRB approval for its joint venture with JOGMEC on the Karonie Gold-Lithium Project, advancing exploration activities with significant soil sampling and drilling underway.

Gold Hydrogen Ltd has reported the detection of rare Helium-3 in its Ramsay Project gas samples, alongside record-high helium purities, while expanding its exploration footprint in South Australia.

Tambourah Metals reports significant high-grade gold assay results from its Pilbara projects and secures government grants to accelerate drilling programs across multiple prospects.

Papyrus Australia has taken significant strides in Q4 2024, signing a joint venture terms sheet in Vietnam, appointing new board members, and securing R&D tax incentives, positioning itself for expanded commercialization.

Arovella Therapeutics has bolstered its financial position with a $20 million placement, fully funding the Phase 1 clinical trial of its lead CAR-iNKT therapy, ALA-101, targeting CD19-positive blood cancers. The company also established a Clinical Advisory Board and anticipates key regulatory and clinical milestones in 2025.

Marquee Resources delivers a robust December quarter update, spotlighting strong drilling results at Redlings Rare Earth Project and a maiden Inferred Mineral Resource Estimate, while advancing exploration across multiple strategic projects.

Andromeda Metals has made significant strides in advancing its Great White Project, progressing funding efforts for Stage 1A+ and securing key operational milestones. The company also bolstered its leadership with new board appointments and received a substantial tax refund, positioning it for a critical investment decision.

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

BCAL Diagnostics is poised to launch its innovative BREASTEST® breast cancer diagnostic test in early 2025, backed by recent NATA accreditation, patent acceptance, and a $2.6 million R&D tax offset.

Northern Minerals reports a 15% increase in its Wolverine Deposit resource and secures $28 million in funding, advancing its Browns Range heavy rare earths project amid ongoing feasibility studies.